Cargando…
Imatinib for COVID-19: A case report
Autores principales: | Morales-Ortega, Alejandro, Bernal-Bello, David, Llarena-Barroso, Cristina, Frutos-Pérez, Begoña, Duarte-Millán, Miguel Ángel, García de Viedma-García, Vanessa, Farfán-Sedano, Ana Isabel, Canalejo-Castrillero, Eduardo, Ruiz-Giardín, José Manuel, Ruiz-Ruiz, Justo, San Martín-López, Juan Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319919/ https://www.ncbi.nlm.nih.gov/pubmed/32599278 http://dx.doi.org/10.1016/j.clim.2020.108518 |
Ejemplares similares
-
Imatinib might constitute a treatment option for lung involvement in COVID-19
por: Bernal-Bello, David, et al.
Publicado: (2020) -
Early clinical experience with imatinib in COVID-19: Searching for a dual effect
por: Morales-Ortega, Alejandro, et al.
Publicado: (2021) -
Imatinib in COVID-19: hope and caution
por: Bernal-Bello, David, et al.
Publicado: (2021) -
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022) -
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind
por: Bernal-Bello, David, et al.
Publicado: (2022)